The acute respiratory distress syndrome (ARDS) devices market is expected to grow at a CAGR of 7.5% during the forecast period of 2023 to 2031. Acute respiratory distress syndrome (ARDS) is a severe lung condition that can be caused by a variety of underlying conditions, including sepsis, pneumonia, and trauma. It is marked by inflammation and fluid accumulation in the lungs, which can lead to breathing difficulties and low blood oxygen levels. ARDS can be fatal if not treated immediately and effectively. For the treatment of ARDS, various devices and equipment are utilized, such as mechanical ventilators, oxygen therapy devices, and extracorporeal membrane oxygenation (ECMO) systems. ARDS monitoring equipment is typically utilized in intensive care units (ICUs) and emergency departments.
ARDS incidence increase is anticipated to drive market growth for acute respiratory distress syndrome devices. ARDS is a severe lung condition characterized by the accumulation of fluid in the air sacs of the lungs. The elderly are highly susceptible to developing this condition. Consequently, geriatric population growth is anticipated to stimulate market expansion over the forecast period. It is anticipated that investment in the R D of new devices will provide lucrative growth opportunities for industry vendors. In the near future, however, high costs and a lack of trained personnel are likely to limit the adoption of ARDS devices. To increase their acute respiratory distress syndrome device market share, vendors are focusing on the introduction of cost-effective products.
The rising number of private hospitals is also anticipated to contribute to market expansion. According to the American Hospital Association Statistics 2022, published in January 2022, there were 2,946 non-profit community hospitals in the United States in 2021, and this number increased to 2,960 in 2022. Consequently, as the number of beds available to treat ARDS patients rises, an increasing number of hospitals will support the growth of the segment over the forecast period.
Increasing hospital admissions and admissions to intensive care units create a demand for ARDS treatment, which drives the market's expansion. According to a study titled "Acute respiratory distress syndrome readmissions: A nationwide cross-sectional analysis of epidemiology and costs of care" published in January 2022 in the PLOS One Journal, 18.4% of patients with acute respiratory distress syndrome were readmitted to the hospital. In addition, according to data published by the Australian Institute of Health and Welfare in May 2022, there will be approximately 11,8 million hospital admissions in 2020-21, which is 6.3% more than in 2019-20. In addition, out of 11.8 million admissions, 7.0% involved an Intensive Care Unit (ICU) stay, 3.8% involved respiratory disease, and 10.3% had a separation mode indicating the patient died in the hospital. Such a rise in emergency critical care admissions creates a demand for ARDS treatment, which is anticipated to propel the growth of this market segment. Thus, the segment is anticipated to exhibit a healthy growth rate over the forecast period due to the aforementioned factors.
According to the National Library of Medicine, a study titled "Acute Respiratory Distress Syndrome" published in February 2022, the incidence of ARDS in the United States ranges from 64,2 to 78.9 cases per 100,000 people per year. Initial ARDS case assessments place 25% of cases in the mild category, while 75% fall into the moderate or severe category. However, one-third of mild cases progress to moderate or severe illnesses.
Consequently, the increasing incidence of acute respiratory distress syndrome in the United States will support market expansion over the forecast period. It is anticipated that the adoption of various organic and inorganic strategies by market leaders will accelerate market expansion. In December 2020, for instance, the Food and Drug Administration (FDA) granted Fast Track designation to Remestemcel-L for the treatment of acute respiratory distress syndrome (ARDS) caused by coronavirus disease (COVID-19). Additionally, in September 2020, Athersys announced that the Regenerative Medicine Advanced Therapy (RMAT) designation was granted to MultiStem cell therapy for the acute respiratory distress syndrome (ARDS) program by the United States Food and Drug Administration.
During the forecast period, the industry in the Asia-Pacific market is projected to expand at a significant rate. The high prevalence of respiratory disorders, the increase in the geriatric population, and the growing awareness of advanced ARDS devices are anticipated to increase regional market statistics.
The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
This product will be delivered within 2 business days.
ARDS incidence increase is anticipated to drive market growth for acute respiratory distress syndrome devices. ARDS is a severe lung condition characterized by the accumulation of fluid in the air sacs of the lungs. The elderly are highly susceptible to developing this condition. Consequently, geriatric population growth is anticipated to stimulate market expansion over the forecast period. It is anticipated that investment in the R D of new devices will provide lucrative growth opportunities for industry vendors. In the near future, however, high costs and a lack of trained personnel are likely to limit the adoption of ARDS devices. To increase their acute respiratory distress syndrome device market share, vendors are focusing on the introduction of cost-effective products.
Increase in ARDS Incidence Boosting Acute Respiratory Distress Syndrome Devices Market Growth
In the coming years, the demand for ARDS devices is projected to increase due to an aging population and a rise in cases of chronic diseases. People over the age of 60 are at increased risk for ARDS and other chronic diseases. The United Nations projects that the global population aged 60 and older will more than double by 2050. Multiple chronic diseases, including obesity, diabetes, and heart disease, are prevalent in the elderly population. In addition, their immune systems are more likely to be compromised, making them more susceptible to infections such as pneumonia. According to the World Health Organization (WHO), approximately 150 million people worldwide are affected by ARDS annually. Consequently, the high prevalence of ARDS is anticipated to contribute to the growth of the acute respiratory distress syndrome devices market in the near future.Research and Development of New Devices
Major acute respiratory distress syndrome device manufacturers are heavily investing in new product research and development. Advanced ARDS devices may improve patient outcomes, shorten hospital stays, and reduce healthcare costs. The Hamilton-T1 ventilator with High-Frequency Oscillation Ventilation (HFOV) technology was introduced by Hamilton Medical in June 2020 to provide advanced ventilation support for critically ill patients. HFOV is a type of mechanical ventilation characterized by rapid, small tidal volume, and high-frequency breaths. This reduces lung damage and improves patient outcomes. Therefore, it is anticipated that the development and introduction of new devices will augment the acute respiratory distress syndrome devices market trajectory in the coming years.Increase in Diagnostic and Monitoring Device Adoption
In accordance with the most recent acute respiratory distress syndrome devices market trends, the diagnostic monitoring devices segment is anticipated to hold the largest market share over the forecast period. For the treatment and management of ARDS, diagnostic and monitoring devices are utilized. In the near future, the prevalence of ARDS is likely to increase demand for these devices. Oxygen saturation levels, lung function, and other vital signs are measured by diagnostic and monitoring equipment. This allows medical personnel to initiate prompt and effective treatment. Detection and treatment of ARDS as early as possible can improve patient outcomes and shorten hospital stays.Hospitals/Clinics by End User Segment is Anticipated to Grow Strongly During the Forecast Period
Hospitals/clinics are well-equipped with advanced technological equipment for surgical procedures and improved treatments, and the hospital segment is experiencing rapid growth due to the growing number of hospital admissions with ARDS, the increasing number of patient pools, and the launch of new products by market players, all of which are expected to continue over the forecast period, thereby driving the segment's growth.The rising number of private hospitals is also anticipated to contribute to market expansion. According to the American Hospital Association Statistics 2022, published in January 2022, there were 2,946 non-profit community hospitals in the United States in 2021, and this number increased to 2,960 in 2022. Consequently, as the number of beds available to treat ARDS patients rises, an increasing number of hospitals will support the growth of the segment over the forecast period.
Increasing hospital admissions and admissions to intensive care units create a demand for ARDS treatment, which drives the market's expansion. According to a study titled "Acute respiratory distress syndrome readmissions: A nationwide cross-sectional analysis of epidemiology and costs of care" published in January 2022 in the PLOS One Journal, 18.4% of patients with acute respiratory distress syndrome were readmitted to the hospital. In addition, according to data published by the Australian Institute of Health and Welfare in May 2022, there will be approximately 11,8 million hospital admissions in 2020-21, which is 6.3% more than in 2019-20. In addition, out of 11.8 million admissions, 7.0% involved an Intensive Care Unit (ICU) stay, 3.8% involved respiratory disease, and 10.3% had a separation mode indicating the patient died in the hospital. Such a rise in emergency critical care admissions creates a demand for ARDS treatment, which is anticipated to propel the growth of this market segment. Thus, the segment is anticipated to exhibit a healthy growth rate over the forecast period due to the aforementioned factors.
North America Remains as the Global Leader
North America held the largest share of the acute respiratory distress syndrome devices market in 2022. Increased incidence of ARDS and other respiratory disorders, rising healthcare expenditures, and the presence of major market players are likely to stimulate market growth in the foreseeable future. Due to the presence of major market players, an increase in product approvals, a developed healthcare system, and a high prevalence of acute respiratory distress syndrome, North America dominated the global ARDS treatment market.According to the National Library of Medicine, a study titled "Acute Respiratory Distress Syndrome" published in February 2022, the incidence of ARDS in the United States ranges from 64,2 to 78.9 cases per 100,000 people per year. Initial ARDS case assessments place 25% of cases in the mild category, while 75% fall into the moderate or severe category. However, one-third of mild cases progress to moderate or severe illnesses.
Consequently, the increasing incidence of acute respiratory distress syndrome in the United States will support market expansion over the forecast period. It is anticipated that the adoption of various organic and inorganic strategies by market leaders will accelerate market expansion. In December 2020, for instance, the Food and Drug Administration (FDA) granted Fast Track designation to Remestemcel-L for the treatment of acute respiratory distress syndrome (ARDS) caused by coronavirus disease (COVID-19). Additionally, in September 2020, Athersys announced that the Regenerative Medicine Advanced Therapy (RMAT) designation was granted to MultiStem cell therapy for the acute respiratory distress syndrome (ARDS) program by the United States Food and Drug Administration.
During the forecast period, the industry in the Asia-Pacific market is projected to expand at a significant rate. The high prevalence of respiratory disorders, the increase in the geriatric population, and the growing awareness of advanced ARDS devices are anticipated to increase regional market statistics.
Market Competition to Intensify During the Forecast Period
The market for acute respiratory distress syndrome is highly competitive and dominated by a handful of major companies. The acute respiratory distress syndrome market is dominated by companies including Faron Pharmaceuticals, BioMarck Pharmaceuticals, GE Healthcare, and Hamilton Company, among others. Other key companies include Koninklijke Philips N.V., Medtronic, Fisher Paykel Healthcare Limited, Dragerwerk AG Co. KGaA, Smiths Medical (ICU Medical), ResMed, and Getinge AB. To expand their regional presence, businesses are adopting a variety of organic and inorganic strategies. Fisher Paykel Healthcare Limited introduced its new Optiflow+ nasal high-flow therapy system in January 2021, which is designed to assist patients with ARDS and other respiratory conditions.Historical Forecast Period
This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2023 to 2031.The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Acute Respiratory Distress Syndrome Devices market are as follows:- Research and development budgets of manufacturers and government spending
- Revenues of key companies in the market segment
- Number of end users and consumption volume, price and value.
- Geographical revenues generate by countries considered in the report
- Micro and macro environment factors that are currently influencing the Acute Respiratory Distress Syndrome Devices market and their expected impact during the forecast period.
Market Segmentation
Type
- Therapeutic Devices
- Mechanical Ventilators
- PAP
- Others
- Diagnostic Monitoring Devices
End-user
- Hospitals
- Specialty Centers
- Others
Injury
- Brain
- Lung
Severity
- Mild
- Moderate
- Severe
Key questions answered in this report
- What are the key micro and macro environmental factors that are impacting the growth of Acute Respiratory Distress Syndrome Devices market?
- What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
- Estimated forecast and market projections up to 2031.
- Which segment accounts for the fastest CAGR during the forecast period?
- Which market segment holds a larger market share and why?
- Are low and middle-income economies investing in the Acute Respiratory Distress Syndrome Devices market?
- Which is the largest regional market for Acute Respiratory Distress Syndrome Devices market?
- What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East Africa?
- Which are the key trends driving Acute Respiratory Distress Syndrome Devices market growth?
- Who are the key competitors and what are their key strategies to enhance their market presence in the Acute Respiratory Distress Syndrome Devices market worldwide?
This product will be delivered within 2 business days.
Table of Contents
1. Preface1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Acute Respiratory Distress Syndrome Devices Market
2.2. Global Acute Respiratory Distress Syndrome Devices Market, By Type, 2022 (US$ Million)
2.3. Global Acute Respiratory Distress Syndrome Devices Market, By End-user, 2022 (US$ Million)
2.4. Global Acute Respiratory Distress Syndrome Devices Market, By Injury, 2022 (US$ Million)
2.5. Global Acute Respiratory Distress Syndrome Devices Market, By Severity, 2022 (US$ Million)
2.6. Global Acute Respiratory Distress Syndrome Devices Market, By Geography, 2022 (US$ Million)
2.7. Attractive Investment Proposition by Geography, 2022
3. Acute Respiratory Distress Syndrome Devices Market: Competitive Analysis
3.1. Market Positioning of Key Acute Respiratory Distress Syndrome Devices Market Vendors
3.2. Strategies Adopted by Acute Respiratory Distress Syndrome Devices Market Vendors
3.3. Key Industry Strategies
3.4. Tier Analysis 2022 Versus 2031
4. Acute Respiratory Distress Syndrome Devices Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Acute Respiratory Distress Syndrome Devices Market Value, 2021 - 2031, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
5. Acute Respiratory Distress Syndrome Devices Market: By Type, 2021-2031, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2022 Versus 2031
5.3. Market Segmentation
5.3.1. Therapeutic Devices
5.3.1.1. Mechanical Ventilators
5.3.1.2. PAP
5.3.1.3. Others
5.3.2. Diagnostic & Monitoring Devices
6. Acute Respiratory Distress Syndrome Devices Market: By End-user, 2021-2031, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2022 Versus 2031
6.3. Market Segmentation
6.3.1. Hospitals
6.3.2. Specialty Centers
6.3.3. Others
7. Acute Respiratory Distress Syndrome Devices Market: By Injury, 2021-2031, USD (Million)
7.1. Market Overview
7.2. Growth & Revenue Analysis: 2022 Versus 2031
7.3. Market Segmentation
7.3.1. Brain
7.3.2. Lung
8. Acute Respiratory Distress Syndrome Devices Market: By Severity, 2021-2031, USD (Million)
8.1. Market Overview
8.2. Growth & Revenue Analysis: 2022 Versus 2031
8.3. Market Segmentation
8.3.1. Mild
8.3.2. Moderate
8.3.3. Severe
9. North America Acute Respiratory Distress Syndrome Devices Market, 2021-2031, USD (Million)
9.1. Market Overview
9.2. Acute Respiratory Distress Syndrome Devices Market: By Type, 2021-2031, USD (Million)
9.3. Acute Respiratory Distress Syndrome Devices Market: By End-user, 2021-2031, USD (Million)
9.4. Acute Respiratory Distress Syndrome Devices Market: By Injury, 2021-2031, USD (Million)
9.5. Acute Respiratory Distress Syndrome Devices Market: By Severity, 2021-2031, USD (Million)
9.6.Acute Respiratory Distress Syndrome Devices Market: By Region, 2021-2031, USD (Million)
9.6.1.North America
9.6.1.1. U.S.
9.6.1.1.1. Acute Respiratory Distress Syndrome Devices Market: By Type, 2021-2031, USD (Million)
9.6.1.1.1. Acute Respiratory Distress Syndrome Devices Market: By End-user, 2021-2031, USD (Million)
9.6.1.1.1. Acute Respiratory Distress Syndrome Devices Market: By Injury, 2021-2031, USD (Million)
9.6.1.1.1. Acute Respiratory Distress Syndrome Devices Market: By Severity, 2021-2031, USD (Million)
9.6.1.2. Canada
9.6.1.2.1. Acute Respiratory Distress Syndrome Devices Market: By Type, 2021-2031, USD (Million)
9.6.1.2.1. Acute Respiratory Distress Syndrome Devices Market: By End-user, 2021-2031, USD (Million)
9.6.1.2.1. Acute Respiratory Distress Syndrome Devices Market: By Injury, 2021-2031, USD (Million)
9.6.1.2.1. Acute Respiratory Distress Syndrome Devices Market: By Severity, 2021-2031, USD (Million)
9.6.1.3. Rest of North America
9.6.1.3.1. Acute Respiratory Distress Syndrome Devices Market: By Type, 2021-2031, USD (Million)
9.6.1.3.1. Acute Respiratory Distress Syndrome Devices Market: By End-user, 2021-2031, USD (Million)
9.6.1.3.1. Acute Respiratory Distress Syndrome Devices Market: By Injury, 2021-2031, USD (Million)
9.6.1.3.1. Acute Respiratory Distress Syndrome Devices Market: By Severity, 2021-2031, USD (Million)
10. UK and European Union Acute Respiratory Distress Syndrome Devices Market, 2021-2031, USD (Million)
10.1. Market Overview
10.2. Acute Respiratory Distress Syndrome Devices Market: By Type, 2021-2031, USD (Million)
10.3. Acute Respiratory Distress Syndrome Devices Market: By End-user, 2021-2031, USD (Million)
10.4. Acute Respiratory Distress Syndrome Devices Market: By Injury, 2021-2031, USD (Million)
10.5. Acute Respiratory Distress Syndrome Devices Market: By Severity, 2021-2031, USD (Million)
10.6.Acute Respiratory Distress Syndrome Devices Market: By Region, 2021-2031, USD (Million)
10.6.1.UK and European Union
10.6.1.1. UK
10.6.1.1.1. Acute Respiratory Distress Syndrome Devices Market: By Type, 2021-2031, USD (Million)
10.6.1.1.1. Acute Respiratory Distress Syndrome Devices Market: By End-user, 2021-2031, USD (Million)
10.6.1.1.1. Acute Respiratory Distress Syndrome Devices Market: By Injury, 2021-2031, USD (Million)
10.6.1.1.1. Acute Respiratory Distress Syndrome Devices Market: By Severity, 2021-2031, USD (Million)
10.6.1.2. Germany
10.6.1.2.1. Acute Respiratory Distress Syndrome Devices Market: By Type, 2021-2031, USD (Million)
10.6.1.2.1. Acute Respiratory Distress Syndrome Devices Market: By End-user, 2021-2031, USD (Million)
10.6.1.2.1. Acute Respiratory Distress Syndrome Devices Market: By Injury, 2021-2031, USD (Million)
10.6.1.2.1. Acute Respiratory Distress Syndrome Devices Market: By Severity, 2021-2031, USD (Million)
10.6.1.3. Spain
10.6.1.3.1. Acute Respiratory Distress Syndrome Devices Market: By Type, 2021-2031, USD (Million)
10.6.1.3.1. Acute Respiratory Distress Syndrome Devices Market: By End-user, 2021-2031, USD (Million)
10.6.1.3.1. Acute Respiratory Distress Syndrome Devices Market: By Injury, 2021-2031, USD (Million)
10.6.1.3.1. Acute Respiratory Distress Syndrome Devices Market: By Severity, 2021-2031, USD (Million)
10.6.1.4. Italy
10.6.1.4.1. Acute Respiratory Distress Syndrome Devices Market: By Type, 2021-2031, USD (Million)
10.6.1.4.1. Acute Respiratory Distress Syndrome Devices Market: By End-user, 2021-2031, USD (Million)
10.6.1.4.1. Acute Respiratory Distress Syndrome Devices Market: By Injury, 2021-2031, USD (Million)
10.6.1.4.1. Acute Respiratory Distress Syndrome Devices Market: By Severity, 2021-2031, USD (Million)
10.6.1.5. France
10.6.1.5.1. Acute Respiratory Distress Syndrome Devices Market: By Type, 2021-2031, USD (Million)
10.6.1.5.1. Acute Respiratory Distress Syndrome Devices Market: By End-user, 2021-2031, USD (Million)
10.6.1.5.1. Acute Respiratory Distress Syndrome Devices Market: By Injury, 2021-2031, USD (Million)
10.6.1.5.1. Acute Respiratory Distress Syndrome Devices Market: By Severity, 2021-2031, USD (Million)
10.6.1.6. Rest of Europe
10.6.1.6.1. Acute Respiratory Distress Syndrome Devices Market: By Type, 2021-2031, USD (Million)
10.6.1.6.1. Acute Respiratory Distress Syndrome Devices Market: By End-user, 2021-2031, USD (Million)
10.6.1.6.1. Acute Respiratory Distress Syndrome Devices Market: By Injury, 2021-2031, USD (Million)
10.6.1.6.1. Acute Respiratory Distress Syndrome Devices Market: By Severity, 2021-2031, USD (Million)
11. Asia Pacific Acute Respiratory Distress Syndrome Devices Market, 2021-2031, USD (Million)
11.1. Market Overview
11.2. Acute Respiratory Distress Syndrome Devices Market: By Type, 2021-2031, USD (Million)
11.3. Acute Respiratory Distress Syndrome Devices Market: By End-user, 2021-2031, USD (Million)
11.4. Acute Respiratory Distress Syndrome Devices Market: By Injury, 2021-2031, USD (Million)
11.5. Acute Respiratory Distress Syndrome Devices Market: By Severity, 2021-2031, USD (Million)
11.6.Acute Respiratory Distress Syndrome Devices Market: By Region, 2021-2031, USD (Million)
11.6.1.Asia Pacific
11.6.1.1. China
11.6.1.1.1. Acute Respiratory Distress Syndrome Devices Market: By Type, 2021-2031, USD (Million)
11.6.1.1.1. Acute Respiratory Distress Syndrome Devices Market: By End-user, 2021-2031, USD (Million)
11.6.1.1.1. Acute Respiratory Distress Syndrome Devices Market: By Injury, 2021-2031, USD (Million)
11.6.1.1.1. Acute Respiratory Distress Syndrome Devices Market: By Severity, 2021-2031, USD (Million)
11.6.1.2. Japan
11.6.1.2.1. Acute Respiratory Distress Syndrome Devices Market: By Type, 2021-2031, USD (Million)
11.6.1.2.1. Acute Respiratory Distress Syndrome Devices Market: By End-user, 2021-2031, USD (Million)
11.6.1.2.1. Acute Respiratory Distress Syndrome Devices Market: By Injury, 2021-2031, USD (Million)
11.6.1.2.1. Acute Respiratory Distress Syndrome Devices Market: By Severity, 2021-2031, USD (Million)
11.6.1.3. India
11.6.1.3.1. Acute Respiratory Distress Syndrome Devices Market: By Type, 2021-2031, USD (Million)
11.6.1.3.1. Acute Respiratory Distress Syndrome Devices Market: By End-user, 2021-2031, USD (Million)
11.6.1.3.1. Acute Respiratory Distress Syndrome Devices Market: By Injury, 2021-2031, USD (Million)
11.6.1.3.1. Acute Respiratory Distress Syndrome Devices Market: By Severity, 2021-2031, USD (Million)
11.6.1.4. Australia
11.6.1.4.1. Acute Respiratory Distress Syndrome Devices Market: By Type, 2021-2031, USD (Million)
11.6.1.4.1. Acute Respiratory Distress Syndrome Devices Market: By End-user, 2021-2031, USD (Million)
11.6.1.4.1. Acute Respiratory Distress Syndrome Devices Market: By Injury, 2021-2031, USD (Million)
11.6.1.4.1. Acute Respiratory Distress Syndrome Devices Market: By Severity, 2021-2031, USD (Million)
11.6.1.5. South Korea
11.6.1.5.1. Acute Respiratory Distress Syndrome Devices Market: By Type, 2021-2031, USD (Million)
11.6.1.5.1. Acute Respiratory Distress Syndrome Devices Market: By End-user, 2021-2031, USD (Million)
11.6.1.5.1. Acute Respiratory Distress Syndrome Devices Market: By Injury, 2021-2031, USD (Million)
11.6.1.5.1. Acute Respiratory Distress Syndrome Devices Market: By Severity, 2021-2031, USD (Million)
11.6.1.6. Rest of Asia Pacific
11.6.1.6.1. Acute Respiratory Distress Syndrome Devices Market: By Type, 2021-2031, USD (Million)
11.6.1.6.1. Acute Respiratory Distress Syndrome Devices Market: By End-user, 2021-2031, USD (Million)
11.6.1.6.1. Acute Respiratory Distress Syndrome Devices Market: By Injury, 2021-2031, USD (Million)
11.6.1.6.1. Acute Respiratory Distress Syndrome Devices Market: By Severity, 2021-2031, USD (Million)
12. Latin America Acute Respiratory Distress Syndrome Devices Market, 2021-2031, USD (Million)
12.1. Market Overview
12.2. Acute Respiratory Distress Syndrome Devices Market: By Type, 2021-2031, USD (Million)
12.3. Acute Respiratory Distress Syndrome Devices Market: By End-user, 2021-2031, USD (Million)
12.4. Acute Respiratory Distress Syndrome Devices Market: By Injury, 2021-2031, USD (Million)
12.5. Acute Respiratory Distress Syndrome Devices Market: By Severity, 2021-2031, USD (Million)
12.6.Acute Respiratory Distress Syndrome Devices Market: By Region, 2021-2031, USD (Million)
12.6.1.Latin America
12.6.1.1. Brazil
12.6.1.1.1. Acute Respiratory Distress Syndrome Devices Market: By Type, 2021-2031, USD (Million)
12.6.1.1.1. Acute Respiratory Distress Syndrome Devices Market: By End-user, 2021-2031, USD (Million)
12.6.1.1.1. Acute Respiratory Distress Syndrome Devices Market: By Injury, 2021-2031, USD (Million)
12.6.1.1.1. Acute Respiratory Distress Syndrome Devices Market: By Severity, 2021-2031, USD (Million)
12.6.1.2. Mexico
12.6.1.2.1. Acute Respiratory Distress Syndrome Devices Market: By Type, 2021-2031, USD (Million)
12.6.1.2.1. Acute Respiratory Distress Syndrome Devices Market: By End-user, 2021-2031, USD (Million)
12.6.1.2.1. Acute Respiratory Distress Syndrome Devices Market: By Injury, 2021-2031, USD (Million)
12.6.1.2.1. Acute Respiratory Distress Syndrome Devices Market: By Severity, 2021-2031, USD (Million)
12.6.1.3. Rest of Latin America
12.6.1.3.1. Acute Respiratory Distress Syndrome Devices Market: By Type, 2021-2031, USD (Million)
12.6.1.3.1. Acute Respiratory Distress Syndrome Devices Market: By End-user, 2021-2031, USD (Million)
12.6.1.3.1. Acute Respiratory Distress Syndrome Devices Market: By Injury, 2021-2031, USD (Million)
12.6.1.3.1. Acute Respiratory Distress Syndrome Devices Market: By Severity, 2021-2031, USD (Million)
13. Middle East and Africa Acute Respiratory Distress Syndrome Devices Market, 2021-2031, USD (Million)
13.1. Market Overview
13.2. Acute Respiratory Distress Syndrome Devices Market: By Type, 2021-2031, USD (Million)
13.3. Acute Respiratory Distress Syndrome Devices Market: By End-user, 2021-2031, USD (Million)
13.4. Acute Respiratory Distress Syndrome Devices Market: By Injury, 2021-2031, USD (Million)
13.5. Acute Respiratory Distress Syndrome Devices Market: By Severity, 2021-2031, USD (Million)
13.6.Acute Respiratory Distress Syndrome Devices Market: By Region, 2021-2031, USD (Million)
13.6.1.Middle East and Africa
13.6.1.1. GCC
13.6.1.1.1. Acute Respiratory Distress Syndrome Devices Market: By Type, 2021-2031, USD (Million)
13.6.1.1.1. Acute Respiratory Distress Syndrome Devices Market: By End-user, 2021-2031, USD (Million)
13.6.1.1.1. Acute Respiratory Distress Syndrome Devices Market: By Injury, 2021-2031, USD (Million)
13.6.1.1.1. Acute Respiratory Distress Syndrome Devices Market: By Severity, 2021-2031, USD (Million)
13.6.1.2. Africa
13.6.1.2.1. Acute Respiratory Distress Syndrome Devices Market: By Type, 2021-2031, USD (Million)
13.6.1.2.1. Acute Respiratory Distress Syndrome Devices Market: By End-user, 2021-2031, USD (Million)
13.6.1.2.1. Acute Respiratory Distress Syndrome Devices Market: By Injury, 2021-2031, USD (Million)
13.6.1.2.1. Acute Respiratory Distress Syndrome Devices Market: By Severity, 2021-2031, USD (Million)
13.6.1.3. Rest of Middle East and Africa
13.6.1.3.1. Acute Respiratory Distress Syndrome Devices Market: By Type, 2021-2031, USD (Million)
13.6.1.3.1. Acute Respiratory Distress Syndrome Devices Market: By End-user, 2021-2031, USD (Million)
13.6.1.3.1. Acute Respiratory Distress Syndrome Devices Market: By Injury, 2021-2031, USD (Million)
13.6.1.3.1. Acute Respiratory Distress Syndrome Devices Market: By Severity, 2021-2031, USD (Million)
14. Company Profile
14.1. Faron Pharmaceuticals
14.1.1. Company Overview
14.1.2. Financial Performance
14.1.3. Product Portfolio
14.1.4. Strategic Initiatives
14.2. BioMarck Pharmaceuticals
14.2.1. Company Overview
14.2.2. Financial Performance
14.2.3. Product Portfolio
14.2.4. Strategic Initiatives
14.3. GE Healthcare
14.3.1. Company Overview
14.3.2. Financial Performance
14.3.3. Product Portfolio
14.3.4. Strategic Initiatives
14.4. Hamilton Company
14.4.1. Company Overview
14.4.2. Financial Performance
14.4.3. Product Portfolio
14.4.4. Strategic Initiatives
14.5. Koninklijke Philips N.V.
14.5.1. Company Overview
14.5.2. Financial Performance
14.5.3. Product Portfolio
14.5.4. Strategic Initiatives
14.6. Medtronic
14.6.1. Company Overview
14.6.2. Financial Performance
14.6.3. Product Portfolio
14.6.4. Strategic Initiatives
14.7. Fisher & Paykel Healthcare Limited
14.7.1. Company Overview
14.7.2. Financial Performance
14.7.3. Product Portfolio
14.7.4. Strategic Initiatives
14.8. Dragerwerk AG & Co. KGaA
14.8.1. Company Overview
14.8.2. Financial Performance
14.8.3. Product Portfolio
14.8.4. Strategic Initiatives
14.9. Smiths Medical (ICU Medical)
14.9.1. Company Overview
14.9.2. Financial Performance
14.9.3. Product Portfolio
14.9.4. Strategic Initiatives
14.10. ResMed
14.10.1. Company Overview
14.10.2. Financial Performance
14.10.3. Product Portfolio
14.10.4. Strategic Initiatives
14.11. Getinge AB.
14.11.1. Company Overview
14.11.2. Financial Performance
14.11.3. Product Portfolio
14.11.4. Strategic Initiatives
14.12. Others
14.12.1. Company Overview
14.12.2. Financial Performance
14.12.3. Product Portfolio
14.12.4. Strategic Initiatives
List of Figures
Figure 1 Global Acute Respiratory Distress Syndrome Devices Market: Market Coverage
Figure 2 Research Methodology and Data Sources
Figure 3 Market Size Estimation - Top Down & Bottom-Up Approach
Figure 4 Global Acute Respiratory Distress Syndrome Devices Market: Quality Assurance
Figure 5 Global Acute Respiratory Distress Syndrome Devices Market, By Type, 2022
Figure 6 Global Acute Respiratory Distress Syndrome Devices Market, By End-user, 2022
Figure 7 Global Acute Respiratory Distress Syndrome Devices Market, By Injury, 2022
Figure 8 Global Acute Respiratory Distress Syndrome Devices Market, By Severity, 2022
Figure 9 Global Acute Respiratory Distress Syndrome Devices Market, By Geography, 2022
Figure 10 Market Geographical Opportunity Matrix - Global Acute Respiratory Distress Syndrome Devices Market, 2022
Figure 11 Market Positioning of Key Acute Respiratory Distress Syndrome Devices Market Players, 2022
Figure 12 Global Acute Respiratory Distress Syndrome Devices Market - Tier Analysis - Percentage of Revenues by Tier Level, 2022 Versus 2031
Figure 13 Global Acute Respiratory Distress Syndrome Devices Market, By Type, 2022 Vs 2031, %
Figure 14 Global Acute Respiratory Distress Syndrome Devices Market, By End-user, 2022 Vs 2031, %
Figure 15 Global Acute Respiratory Distress Syndrome Devices Market, By Injury, 2022 Vs 2031, %
Figure 16 Global Acute Respiratory Distress Syndrome Devices Market, By Severity, 2022 Vs 2031, %
Figure 17 U.S. Acute Respiratory Distress Syndrome Devices Market (US$ Million), 2021 - 2031
Figure 18 Canada Acute Respiratory Distress Syndrome Devices Market (US$ Million), 2021 - 2031
Figure 19 Rest of North America Acute Respiratory Distress Syndrome Devices Market (US$ Million), 2021 - 2031
Figure 20 UK Acute Respiratory Distress Syndrome Devices Market (US$ Million), 2021 - 2031
Figure 21 Germany Acute Respiratory Distress Syndrome Devices Market (US$ Million), 2021 - 2031
Figure 22 Spain Acute Respiratory Distress Syndrome Devices Market (US$ Million), 2021 - 2031
Figure 23 Italy Acute Respiratory Distress Syndrome Devices Market (US$ Million), 2021 - 2031
Figure 24 France Acute Respiratory Distress Syndrome Devices Market (US$ Million), 2021 - 2031
Figure 25 Rest of Europe Acute Respiratory Distress Syndrome Devices Market (US$ Million), 2021 - 2031
Figure 26 China Acute Respiratory Distress Syndrome Devices Market (US$ Million), 2021 - 2031
Figure 27 Japan Acute Respiratory Distress Syndrome Devices Market (US$ Million), 2021 - 2031
Figure 28 India Acute Respiratory Distress Syndrome Devices Market (US$ Million), 2021 - 2031
Figure 29 Australia Acute Respiratory Distress Syndrome Devices Market (US$ Million), 2021 - 2031
Figure 30 South Korea Acute Respiratory Distress Syndrome Devices Market (US$ Million), 2021 - 2031
Figure 31 Rest of Asia Acute Respiratory Distress Syndrome Devices Market (US$ Million), 2021 - 2031
Figure 32 Brazil Acute Respiratory Distress Syndrome Devices Market (US$ Million), 2021 - 2031
Figure 33 Mexico Acute Respiratory Distress Syndrome Devices Market (US$ Million), 2021 - 2031
Figure 34 Rest of Latin America Acute Respiratory Distress Syndrome Devices Market (US$ Million), 2021 - 2031
Figure 35 GCC Acute Respiratory Distress Syndrome Devices Market (US$ Million), 2021 - 2031
Figure 36 Africa Acute Respiratory Distress Syndrome Devices Market (US$ Million), 2021 - 2031
Figure 37 Rest of Middle East and Africa Acute Respiratory Distress Syndrome Devices Market (US$ Million), 2021 - 2031
List of Tables
Table 1 Global Acute Respiratory Distress Syndrome Devices Market By Type, 2021-2031, USD (Million)
Table 2 Global Acute Respiratory Distress Syndrome Devices Market By Therapeutic Devices, 2021-2031, USD (Million)
Table 3 Global Acute Respiratory Distress Syndrome Devices Market By End-user, 2021-2031, USD (Million)
Table 4 Global Acute Respiratory Distress Syndrome Devices Market By Injury, 2021-2031, USD (Million)
Table 5 Global Acute Respiratory Distress Syndrome Devices Market By Severity, 2021-2031, USD (Million)
Table 6 North America Acute Respiratory Distress Syndrome Devices Market By Type, 2021-2031, USD (Million)
Table 7 North America Acute Respiratory Distress Syndrome Devices Market By Therapeutic Devices, 2021-2031, USD (Million)
Table 8 North America Acute Respiratory Distress Syndrome Devices Market By End-user, 2021-2031, USD (Million)
Table 9 North America Acute Respiratory Distress Syndrome Devices Market By Injury, 2021-2031, USD (Million)
Table 10 North America Acute Respiratory Distress Syndrome Devices Market By Severity, 2021-2031, USD (Million)
Table 11 U.S. Acute Respiratory Distress Syndrome Devices Market By Type, 2021-2031, USD (Million)
Table 12 U.S. Acute Respiratory Distress Syndrome Devices Market By Therapeutic Devices, 2021-2031, USD (Million)
Table 13 U.S. Acute Respiratory Distress Syndrome Devices Market By End-user, 2021-2031, USD (Million)
Table 14 U.S. Acute Respiratory Distress Syndrome Devices Market By Injury, 2021-2031, USD (Million)
Table 15 U.S. Acute Respiratory Distress Syndrome Devices Market By Severity, 2021-2031, USD (Million)
Table 16 Canada Acute Respiratory Distress Syndrome Devices Market By Type, 2021-2031, USD (Million)
Table 17 Canada Acute Respiratory Distress Syndrome Devices Market By Therapeutic Devices, 2021-2031, USD (Million)
Table 18 Canada Acute Respiratory Distress Syndrome Devices Market By End-user, 2021-2031, USD (Million)
Table 19 Canada Acute Respiratory Distress Syndrome Devices Market By Injury, 2021-2031, USD (Million)
Table 20 Canada Acute Respiratory Distress Syndrome Devices Market By Severity, 2021-2031, USD (Million)
Table 21 Rest of North America Acute Respiratory Distress Syndrome Devices Market By Type, 2021-2031, USD (Million)
Table 22 Rest of North America Acute Respiratory Distress Syndrome Devices Market By Therapeutic Devices, 2021-2031, USD (Million)
Table 23 Rest of North America Acute Respiratory Distress Syndrome Devices Market By End-user, 2021-2031, USD (Million)
Table 24 Rest of North America Acute Respiratory Distress Syndrome Devices Market By Injury, 2021-2031, USD (Million)
Table 25 Rest of North America Acute Respiratory Distress Syndrome Devices Market By Severity, 2021-2031, USD (Million)
Table 26 UK and European Union Acute Respiratory Distress Syndrome Devices Market By Type, 2021-2031, USD (Million)
Table 27 UK and European Union Acute Respiratory Distress Syndrome Devices Market By Therapeutic Devices, 2021-2031, USD (Million)
Table 28 UK and European Union Acute Respiratory Distress Syndrome Devices Market By End-user, 2021-2031, USD (Million)
Table 29 UK and European Union Acute Respiratory Distress Syndrome Devices Market By Injury, 2021-2031, USD (Million)
Table 30 UK and European Union Acute Respiratory Distress Syndrome Devices Market By Severity, 2021-2031, USD (Million)
Table 31 UK Acute Respiratory Distress Syndrome Devices Market By Type, 2021-2031, USD (Million)
Table 32 UK Acute Respiratory Distress Syndrome Devices Market By Therapeutic Devices, 2021-2031, USD (Million)
Table 33 UK Acute Respiratory Distress Syndrome Devices Market By End-user, 2021-2031, USD (Million)
Table 34 UK Acute Respiratory Distress Syndrome Devices Market By Injury, 2021-2031, USD (Million)
Table 35 UK Acute Respiratory Distress Syndrome Devices Market By Severity, 2021-2031, USD (Million)
Table 36 Germany Acute Respiratory Distress Syndrome Devices Market By Type, 2021-2031, USD (Million)
Table 37 Germany Acute Respiratory Distress Syndrome Devices Market By Therapeutic Devices, 2021-2031, USD (Million)
Table 38 Germany Acute Respiratory Distress Syndrome Devices Market By End-user, 2021-2031, USD (Million)
Table 39 Germany Acute Respiratory Distress Syndrome Devices Market By Injury, 2021-2031, USD (Million)
Table 40 Germany Acute Respiratory Distress Syndrome Devices Market By Severity, 2021-2031, USD (Million)
Table 41 Spain Acute Respiratory Distress Syndrome Devices Market By Type, 2021-2031, USD (Million)
Table 42 Spain Acute Respiratory Distress Syndrome Devices Market By Therapeutic Devices, 2021-2031, USD (Million)
Table 43 Spain Acute Respiratory Distress Syndrome Devices Market By End-user, 2021-2031, USD (Million)
Table 44 Spain Acute Respiratory Distress Syndrome Devices Market By Injury, 2021-2031, USD (Million)
Table 45 Spain Acute Respiratory Distress Syndrome Devices Market By Severity, 2021-2031, USD (Million)
Table 46 Italy Acute Respiratory Distress Syndrome Devices Market By Type, 2021-2031, USD (Million)
Table 47 Italy Acute Respiratory Distress Syndrome Devices Market By Therapeutic Devices, 2021-2031, USD (Million)
Table 48 Italy Acute Respiratory Distress Syndrome Devices Market By End-user, 2021-2031, USD (Million)
Table 49 Italy Acute Respiratory Distress Syndrome Devices Market By Injury, 2021-2031, USD (Million)
Table 50 Italy Acute Respiratory Distress Syndrome Devices Market By Severity, 2021-2031, USD (Million)
Table 51 France Acute Respiratory Distress Syndrome Devices Market By Type, 2021-2031, USD (Million)
Table 52 France Acute Respiratory Distress Syndrome Devices Market By Therapeutic Devices, 2021-2031, USD (Million)
Table 53 France Acute Respiratory Distress Syndrome Devices Market By End-user, 2021-2031, USD (Million)
Table 54 France Acute Respiratory Distress Syndrome Devices Market By Injury, 2021-2031, USD (Million)
Table 55 France Acute Respiratory Distress Syndrome Devices Market By Severity, 2021-2031, USD (Million)
Table 56 Rest of Europe Acute Respiratory Distress Syndrome Devices Market By Type, 2021-2031, USD (Million)
Table 57 Rest of Europe Acute Respiratory Distress Syndrome Devices Market By Therapeutic Devices, 2021-2031, USD (Million)
Table 58 Rest of Europe Acute Respiratory Distress Syndrome Devices Market By End-user, 2021-2031, USD (Million)
Table 59 Rest of Europe Acute Respiratory Distress Syndrome Devices Market By Injury, 2021-2031, USD (Million)
Table 60 Rest of Europe Acute Respiratory Distress Syndrome Devices Market By Severity, 2021-2031, USD (Million)
Table 61 Asia Acute Respiratory Distress Syndrome Devices Market By Type, 2021-2031, USD (Million)
Table 62 Asia Acute Respiratory Distress Syndrome Devices Market By Therapeutic Devices, 2021-2031, USD (Million)
Table 63 Asia Acute Respiratory Distress Syndrome Devices Market By End-user, 2021-2031, USD (Million)
Table 64 Asia Acute Respiratory Distress Syndrome Devices Market By Injury, 2021-2031, USD (Million)
Table 65 Asia Acute Respiratory Distress Syndrome Devices Market By Severity, 2021-2031, USD (Million)
Table 66 China Acute Respiratory Distress Syndrome Devices Market By Type, 2021-2031, USD (Million)
Table 67 China Acute Respiratory Distress Syndrome Devices Market By Therapeutic Devices, 2021-2031, USD (Million)
Table 68 China Acute Respiratory Distress Syndrome Devices Market By End-user, 2021-2031, USD (Million)
Table 69 China Acute Respiratory Distress Syndrome Devices Market By Injury, 2021-2031, USD (Million)
Table 70 China Acute Respiratory Distress Syndrome Devices Market By Severity, 2021-2031, USD (Million)
Table 71 Japan Acute Respiratory Distress Syndrome Devices Market By Type, 2021-2031, USD (Million)
Table 72 Japan Acute Respiratory Distress Syndrome Devices Market By Therapeutic Devices, 2021-2031, USD (Million)
Table 73 Japan Acute Respiratory Distress Syndrome Devices Market By End-user, 2021-2031, USD (Million)
Table 74 Japan Acute Respiratory Distress Syndrome Devices Market By Injury, 2021-2031, USD (Million)
Table 75 Japan Acute Respiratory Distress Syndrome Devices Market By Severity, 2021-2031, USD (Million)
Table 76 India Acute Respiratory Distress Syndrome Devices Market By Type, 2021-2031, USD (Million)
Table 77 India Acute Respiratory Distress Syndrome Devices Market By Therapeutic Devices, 2021-2031, USD (Million)
Table 78 India Acute Respiratory Distress Syndrome Devices Market By End-user, 2021-2031, USD (Million)
Table 79 India Acute Respiratory Distress Syndrome Devices Market By Injury, 2021-2031, USD (Million)
Table 80 India Acute Respiratory Distress Syndrome Devices Market By Severity, 2021-2031, USD (Million)
Table 81 Australia Acute Respiratory Distress Syndrome Devices Market By Type, 2021-2031, USD (Million)
Table 82 Australia Acute Respiratory Distress Syndrome Devices Market By Therapeutic Devices, 2021-2031, USD (Million)
Table 83 Australia Acute Respiratory Distress Syndrome Devices Market By End-user, 2021-2031, USD (Million)
Table 84 Australia Acute Respiratory Distress Syndrome Devices Market By Injury, 2021-2031, USD (Million)
Table 85 Australia Acute Respiratory Distress Syndrome Devices Market By Severity, 2021-2031, USD (Million)
Table 86 South Korea Acute Respiratory Distress Syndrome Devices Market By Type, 2021-2031, USD (Million)
Table 87 South Korea Acute Respiratory Distress Syndrome Devices Market By Therapeutic Devices, 2021-2031, USD (Million)
Table 88 South Korea Acute Respiratory Distress Syndrome Devices Market By End-user, 2021-2031, USD (Million)
Table 89 South Korea Acute Respiratory Distress Syndrome Devices Market By Injury, 2021-2031, USD (Million)
Table 90 South Korea Acute Respiratory Distress Syndrome Devices Market By Severity, 2021-2031, USD (Million)
Table 91 Latin America Acute Respiratory Distress Syndrome Devices Market By Type, 2021-2031, USD (Million)
Table 92 Latin America Acute Respiratory Distress Syndrome Devices Market By Therapeutic Devices, 2021-2031, USD (Million)
Table 93 Latin America Acute Respiratory Distress Syndrome Devices Market By End-user, 2021-2031, USD (Million)
Table 94 Latin America Acute Respiratory Distress Syndrome Devices Market By Injury, 2021-2031, USD (Million)
Table 95 Latin America Acute Respiratory Distress Syndrome Devices Market By Severity, 2021-2031, USD (Million)
Table 96 Brazil Acute Respiratory Distress Syndrome Devices Market By Type, 2021-2031, USD (Million)
Table 97 Brazil Acute Respiratory Distress Syndrome Devices Market By Therapeutic Devices, 2021-2031, USD (Million)
Table 98 Brazil Acute Respiratory Distress Syndrome Devices Market By End-user, 2021-2031, USD (Million)
Table 99 Brazil Acute Respiratory Distress Syndrome Devices Market By Injury, 2021-2031, USD (Million)
Table 100 Brazil Acute Respiratory Distress Syndrome Devices Market By Severity, 2021-2031, USD (Million)
Table 101 Mexico Acute Respiratory Distress Syndrome Devices Market By Type, 2021-2031, USD (Million)
Table 102 Mexico Acute Respiratory Distress Syndrome Devices Market By Therapeutic Devices, 2021-2031, USD (Million)
Table 103 Mexico Acute Respiratory Distress Syndrome Devices Market By End-user, 2021-2031, USD (Million)
Table 104 Mexico Acute Respiratory Distress Syndrome Devices Market By Injury, 2021-2031, USD (Million)
Table 105 Mexico Acute Respiratory Distress Syndrome Devices Market By Severity, 2021-2031, USD (Million)
Table 106 Rest of Latin America Acute Respiratory Distress Syndrome Devices Market By Type, 2021-2031, USD (Million)
Table 107 Rest of Latin America Acute Respiratory Distress Syndrome Devices Market By Therapeutic Devices, 2021-2031, USD (Million)
Table 108 Rest of Latin America Acute Respiratory Distress Syndrome Devices Market By End-user, 2021-2031, USD (Million)
Table 109 Rest of Latin America Acute Respiratory Distress Syndrome Devices Market By Injury, 2021-2031, USD (Million)
Table 110 Rest of Latin America Acute Respiratory Distress Syndrome Devices Market By Severity, 2021-2031, USD (Million)
Table 111 Middle East and Africa Acute Respiratory Distress Syndrome Devices Market By Type, 2021-2031, USD (Million)
Table 112 Middle East and Africa Acute Respiratory Distress Syndrome Devices Market By Therapeutic Devices, 2021-2031, USD (Million)
Table 113 Middle East and Africa Acute Respiratory Distress Syndrome Devices Market By End-user, 2021-2031, USD (Million)
Table 114 Middle East and Africa Acute Respiratory Distress Syndrome Devices Market By Injury, 2021-2031, USD (Million)
Table 115 Middle East and Africa Acute Respiratory Distress Syndrome Devices Market By Severity, 2021-2031, USD (Million)
Table 116 GCC Acute Respiratory Distress Syndrome Devices Market By Type, 2021-2031, USD (Million)
Table 117 GCC Acute Respiratory Distress Syndrome Devices Market By Therapeutic Devices, 2021-2031, USD (Million)
Table 118 GCC Acute Respiratory Distress Syndrome Devices Market By End-user, 2021-2031, USD (Million)
Table 119 GCC Acute Respiratory Distress Syndrome Devices Market By Injury, 2021-2031, USD (Million)
Table 120 GCC Acute Respiratory Distress Syndrome Devices Market By Severity, 2021-2031, USD (Million)
Table 121 Africa Acute Respiratory Distress Syndrome Devices Market By Type, 2021-2031, USD (Million)
Table 122 Africa Acute Respiratory Distress Syndrome Devices Market By Therapeutic Devices, 2021-2031, USD (Million)
Table 123 Africa Acute Respiratory Distress Syndrome Devices Market By End-user, 2021-2031, USD (Million)
Table 124 Africa Acute Respiratory Distress Syndrome Devices Market By Injury, 2021-2031, USD (Million)
Table 125 Africa Acute Respiratory Distress Syndrome Devices Market By Severity, 2021-2031, USD (Million)
Table 126 Rest of Middle East and Africa Acute Respiratory Distress Syndrome Devices Market By Type, 2021-2031, USD (Million)
Table 127 Rest of Middle East and Africa Acute Respiratory Distress Syndrome Devices Market By Therapeutic Devices, 2021-2031, USD (Million)
Table 128 Rest of Middle East and Africa Acute Respiratory Distress Syndrome Devices Market By End-user, 2021-2031, USD (Million)
Table 129 Rest of Middle East and Africa Acute Respiratory Distress Syndrome Devices Market By Injury, 2021-2031, USD (Million)
Table 130 Rest of Middle East and Africa Acute Respiratory Distress Syndrome Devices Market By Severity, 2021-2031, USD (Million)
Companies Mentioned
- Faron Pharmaceuticals
- BioMarck Pharmaceuticals
- GE Healthcare
- Hamilton Company
- Koninklijke Philips N.V.
- Medtronic
- Fisher & Paykel Healthcare Limited
- Dragerwerk AG & Co. KGaA
- Smiths Medical (ICU Medical)
- ResMed
- Getinge AB
